198 filings
Page 2 of 10
8-K
a86xsj6t621p
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
f4yatiq z2
4 Nov 22
Departure of Directors or Certain Officers
4:54pm
8-K
j0k18zj0zjni2797dp
27 Jul 22
Alimera Sciences Announces Second Quarter 2022 Financial Results
8:22am
8-K
a1z5j
13 Jul 22
Submission of Matters to a Vote of Security Holders
4:25pm
8-K
cnxdc6i
7 Jun 22
Regulation FD Disclosure
8:56am
8-K
cjlgg0d7wym37h 4j
9 May 22
Alimera Sciences Reports First Quarter 2022 Results
8:40am
8-K
gtrfju8
25 Feb 22
Entry into a Material Definitive Agreement
6:17pm
8-K
gyhm qo16a
24 Feb 22
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
8:15am
8-K
l66l47fpzbk04
1 Dec 21
Alimera Sciences Welcomes Ophthalmic Strategic Consultant
8:27am
8-K
hl5ho is1wu6
28 Oct 21
Alimera Sciences Announces Third Quarter 2021 Financial Results
8:10am
8-K
3pmb6q0khpp50ql32
13 Aug 21
Alimera Sciences Announces Second Quarter 2021 Financial Results
8:16am
8-K
0exq hykfbe
16 Jun 21
Departure of Directors or Certain Officers
5:06pm
8-K
uea1jgupww6j1kmuvf8
28 Apr 21
Alimera Sciences Announces First Quarter 2021 Financial Results
4:40pm
8-K
5uqwpky0mpmhtbnxf2
14 Apr 21
Alimera Sciences receives $20 million
9:12am
8-K
o9ex fioe462
30 Mar 21
Entry into a Material Definitive Agreement
12:00am
8-K
lwaeo
24 Feb 21
Alimera Sciences Reports Fourth Quarter and 2020 Results
4:39pm
8-K
9dah jr3ui8
19 Feb 21
Regulation FD Disclosure
5:07pm
8-K
wq2n14d ivsp
19 Jan 21
Alimera Sciences Announces Preliminary Top-line Results for Fourth Quarter and Full-Year 2020
4:37pm
8-K
xiq4n
8 Jan 21
Regulation FD Disclosure
4:09pm
8-K
w925w u1bsx
28 Oct 20
Alimera Sciences Announces Third Quarter 2020 Financial Results
4:19pm